The Partnership for Research on Ebola Virus in Liberia, PREVAIL, Monday announced the expansion of the Ebola vaccine study at Redemption Hospital. The study will assess three different test vaccine strategies in an effort to find which show the most promise to prevent or quickly control future Ebola outbreaks. The start of the expansion of the Ebola vaccine study in Liberia follows a similar effort of the multi-country study, which started in Guinea on March 27, 2017. This is the first large-scale clinical study being coordinated by the international Partnership for Research on Ebola VACcination (PREVAC). It will assess the safety and ability of each of three different Ebola vaccine strategies to stimulate an immune response to the virus that may be protective.

Source: GNN Liberia April 04, 2017 19:30 UTC